Poseida Therapeutics Expands Executive Leadership Team

Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, announced the expansion of the company’s executive team with several key appointments.  Matthew Spear, M.D., has been appointed Chief Medical Officer, Ryan Takeya has been appointed Vice President, Technical Operations, and Glenn Dourado has been appointed Vice President, Business Development.